CAJ | 학술논문

蛛网膜下腔出血（ SAH）是最常见的脑血管疾病之一。近年来，随着医疗水平的提高，动脉瘤经治疗后再出血的风险已很小，患者生存机会大大提高，但 SAH后脑血管痉挛（ CVS）的发生率却很高。预防和治疗SAH后CVS是神经外科医师面临的一个重大课题。氧合血红蛋白被广泛认为是SAH后致CVS各种原因中最重要的启动因素，而血管内皮细胞生长因子作为一种特异性内皮细胞有丝分裂原，对SAH后CVS发生有至关重要的作用，也是目前国内外研究CVS因素的热点。
주망막하강출혈（ SAH）시최상견적뇌혈관질병지일。근년래，수착의료수평적제고，동맥류경치료후재출혈적풍험이흔소，환자생존궤회대대제고，단 SAH후뇌혈관경련（ CVS）적발생솔각흔고。예방화치료SAH후CVS시신경외과의사면림적일개중대과제。양합혈홍단백피엄범인위시SAH후치CVS각충원인중최중요적계동인소，이혈관내피세포생장인자작위일충특이성내피세포유사분렬원，대SAH후CVS발생유지관중요적작용，야시목전국내외연구CVS인소적열점。
Subarachnoid hemorrhage ( SAH ) is one of the most common cerebrovascular diseases.In recent years,as the development of medical technology, the risk of re-hemorrhage is very small after treatment and the survival of patients are improved greatly,however the incidence of cerebral vasospasm(CVS) after SAH is high.The prevention and treatment of CVS after SAH is a major task of neuro-surgeons.Oxyhemo-globin is considered to be the most important initiating factor of CVS after SAH , and vascular endothelial growth factor also plays a crucial role in CVS,both of which are hotspots of research about CVS factors in and out of China.